News
Novo Nordisk A/S (NYSE: NVO) is one of the high-margin pharma stocks to buy now. Berenberg has reaffirmed its Hold rating on ...
UnitedHealth Group's pharmacy benefits manager, OptumRx Inc., was hit with an Employee Retirement Income Security Act of 1974 ...
It turns out that obesity may be much more complicated than we thought, with the condition potentially existing in up to 11 ...
From legal pitfalls to temperature-sensitive drugs, here’s how to travel safely and legally with your medication ...
7h
Zacks Investment Research on MSNCan Wegovy & Ozempic Drive Another Strong Quarter for Novo Nordisk?Novo Nordisk NVO generates most of its revenues from the sales of its blockbuster GLP-1 injections, Ozempic for type II ...
On April 29, 2025, Hims & Hers and Novo Nordisk unveiled a landmark collaboration to bring Wegovy—Novo's blockbuster semaglutide-based weight‑loss injection—to Hims & Hers' digital storefront. The ...
But taking them abroad isn’t always simple. From legal pitfalls to temperature-sensitive drugs, here’s how to travel safely and legally with your medication. Medicines that are legal in the UK can be ...
KATIE Price has revealed her son Harvey now weighs 30st, as she gave fans an update on him taking weight loss jabs. The ...
In Novo Nordisk A/S’s home country of Denmark, the popularity of weight-loss drugs is fueling economic growth, but local ...
Lawmakers are trying to restore access to GLP-1 weight loss drugs, like Ozempic and Wegovy, after Ohio removed medical ...
22h
India Today on MSNUS employers to cut health benefits amid soaring weight-loss drug costs: SurveyOver half of large US employers plan to cut health benefits in 2026 as rising costs of weight-loss drugs like Wegovy drive up spending, Mercer's latest survey reveals.
Health plan trustees at a Minneapolis- based construction workers union are suing a subsidiary of UnitedHealth Group for paying more than $4 million for costly weight-loss drugs, depleting union funds ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results